In the News

Medidata is creating a buzz in the scientific and IT communities. Here are just a few stories highlighting recent successes.

2014

The September issue of Pharma Times features an article on the "Internet of Things"—the connection of different devices and applications via the internetand how it's opening new doors for the pharma industry. Medidata's SVP for research & development Andrew Newbigging is featured in the article, discussing how innovative technology like point-to-point diagnostics and wearable personal devices are helping to streamline the data collection process.
Read

Applied Clinical Trials online features a recent article by Medidata's VP of quality and regulatory affairs Frances Nolan. The article presents the audit challenges for clinical trial software suppliers and suggests value-based alternatives—including remote audits and group audits—that offer productive ways to comply with regulatory and business requirements. 
Read

Life Science Leader's September issue features a byline on adaptive trials by Medidata’s VP of product development Michelle Marlborough. In her piece, Michelle explains how an integrated platform that incorporates EDC, randomization and a CTMS allows sponsors to ease the operational complexity of adaptive trials, which are intended to test new treatments in less time, at a fraction of the cost and with significantly fewer participants than traditional trials.
Read

The PharmaVOICE September cover story, which explores the power of digital technology to fuel patients’ quest for better health and the industry’s efforts to keep pace with their digital needs, features insight from Medidata's global lead for Patient Cloud Anne Zielinski. Anne’s quotes can be found on pages 10 and 14 of this month’s issue.
Read

Medidata's VP of the EMEA mid-market Richard Young is interviewed by the UK-publication The Pharma Letter on how big data is playing an increasing role in drug development and clinical trials. As the pharmaceutical and biotechnology industries continue to switch from paper-based to software-based studies, Richard discusses how making the switch to digital can help make running clinical trials simpler, faster and more cost-effective.
Read

Medidata's director of the Asia-Pacific region Takeru Yamamoto is featured in a recent Korea Economic Daily article, in which he describes how Medidata's technology can help contribute to the growing Korean clinical development market. Please note this article is written in Korean.
Read 

Medidata’s vice president of product strategy Michelle Marlborough has been honored with the PharmaVOICE 100 award, an annual list of individuals recognized for translating industry issues into opportunities and pioneering new paths to success for the life sciences. PharmaVOICE ​recognized Michelle as a driving force behind Medidata’s success in transforming clinical trials ​through innovative, cloud-based technology and analytics.
Read

Data intelligence company Sumo Logic issued a press release announcing that Medidata has selected its managed security service for new advancements in data security. Sumo Logic's THG Cloud SIEM, which provides data analytics and real-time dashboards on network usage, complements Medidata's industry-leading security protections. Glenn Watt, Medidata VP of information security, says these new advancements provide "a manageable, actionable, and proactive view of emerging security concerns that most companies never get a glimpse of."
Read

CenterWatch article outlines the findings of a recent survey on facilitated reviews, conducted by Medidata and the Tufts Center for the Study of Drug Development (CSDD)​. The survey analyzed if and how the practice is being used by life science organizations, revealing that 73 percent of ​participating ​companies have the meetings in place and that the majority of respondents saw a decrease in the number of protocol amendments and protocol complexity.
Read

In a recent interview with online Korean publication Yakup, Medidata president Glen de Vries discusses the company's growing presence in the South Korean clinical trial market, as well as the important role its solutions play to accelerate drug development and better health care. Please note this article is written in Korean.
Read

In a recent Ovum analyst report on the CTMS market, Medidata CTMS was ranked number one in overall execution and deployment against other CTMS vendors due to its frequent upgrade schedule and rapid deployment model—features that its cloud platform and agile development methodology afford. The overall assessment attributes Medidata CTMS' market leadership to its breadth of offerings, modularized, cloud-based platform approach and market share.
Read

In a recent PharmaTimes article, Medidata product specialist Rebecca Jackson shares her views on how cloud technologies are making clinical trials more flexible, accessible and usable for researchers, clinicians and patients. She notes that technology is shifting to cloud-based, open solutions characterized by social networking and downloadable apps, making it easier for patients to participate.
Read

A recent ​​Forbes article on digital asset planning for financial advisers cites Medidata as a leading cloud-based technology company. The piece features Medidata’s SVP and chief data officer David Lee, and highlights the importance of growing, maintaining and supporting Medidata's digital assets—particularly its scientific and operational data—for the success of its clients’ clinical R&D.
Read

In a recent Bloomberg News article, Medidata president Glen de Vries talks about how the right data can be used to help companies make more informed decisions, as well as help streamline clinical development and improve the clinical trial experience for patients.
Read

In an interview with Eyeforpharma, Medidata’s SVP of research and development Andrew Newbigging explains how software companies like Medidata are providing opportunities for the life science industry to streamline the clinical trial process from design to analysis, promising to help the industry make significant savings across Phase-II and Phase-III trials.
Read

A recent CenterWatch article discusses the joint project between Medidata and TransCelerate BioPharma Inc., which will leveraging operational data available through the Medidata Clinical Cloud™ to help assess the benefits and challenges associated with risk-based monitoring of sites.
Read

In the May issue of HR Magazine, Medidata's vice president of platform architecture Isaac Wong is featured in an article discussing the evolution of hacking and how companies are now conducting hackathons to find technology solutions, collaborate on new ideas and improve employee engagement.
Read

FierceCRO reports on the recent partnership announcement between Medidata and TransCelerate BioPharma Inc., which will use Medidata metrics and analytics to better understand the benefits of risk-based monitoring and "modernize the way the industry conducts clinical trials."
Read

FierceBiotechIT article discusses Medidata's presence in the risk-based monitoring sector, highlighting the recent Medidata-TransCelerate BioPharma Inc. joint initiative and Sanofi's adoption of Medidata’s targeted source document verification (TSDV) tool.
Read 

Outsourcing-Pharma.com reports on the recent Medidata and TransCelerate BioPharma Inc. joint initiative, which will use Medidata technology to analyze the contribution of source document verification (SDV) to overall clinical data quality. 
Read

Applied Clinical Trials online features a recent blog post by Medidata's Rafael Campo, in which he explores the cost and complexity differences in pediatric vs. adult clinical trials using Medidata’s PICAS® database.
Read 

Medidata president Glen de Vries is featured in a recent Outsourced Pharma article, in which he explores the potential for mHealth to transform the world of clinical trials and the need for companies to embrace and adopt new solutions.
Read

Chief editor of Outsourced Pharma and Clinical Leader Ed Miseta sits down with Medidata’s vice president of product strategy Michelle Marlborough—recently named an industry “Rising Star” by the Healthcare Businesswomen’s Association (HBA)—to discuss her career path and the influence technology has had in changing clinical trials.
Read

In the May issue of PharmaVOICE, Medidata’s vice president of product strategy Michelle Marlborough—recently named an industry “Rising Star” by the Healthcare Businesswomen’s Association (HBA)—pays tribute to those who have helped her develop into her role today, as well as discusses the tools and techniques she uses to hone in on her leadership skills. Profiled along with the other 2014 HBA Rising Stars, Michelle's insight can be found on pg. 1, 8 and 20 of the PDF article reprint.
Read

Applied Clinical Trials online in April features a Medidata Insights™ benchmark blog showcasing site monitor visit rates over the past four years. Part of a series highlighting industry metrics, this edition focuses on the correlation between the downward trend in the number of visit days per year, per site and the increase in the rate of auto queries.
Read

Clinical Leader reports on Theorem Clinical Research's recently expanded Medidata partnership through its accreditation for Medidata Patient Cloud™.
Read

In a recent Clinical Leader article exploring mHealth solutions and their potential to transform clinical trials, Medidata president Glen de Vries offers insight around their ability to recruit and retain patients in new ways while simultaneously increase trial efficiency and reduce costs.
Read

Medidata president Glen de Vries is featured in a recent Newsweek article exploring technology's potential to make drugs smarter and increase the efficacy and value of medicine, guiding patients to wellness.
Read

Fox 5 New York stopped by Medidata's NYC headquarters to talk to Medidata president Glen de Vries about "smart pills" and the future of personalized medicine, highlighting how smartphones and other innovative technologies will soon be part of a solution that will maximize the therapeutic value of and change the way patients take their medicine.
View

In the April 2 issue of Yakuji Nippo, Medidata's vice president of APAC sales Takeru Yamamoto details the Medidata platform, highlighting its ability to optimize the clinical development process by harnessing real-world trial data. *Please note this article is written in Japanese
Read

Applied Clinical Trials online spotlights Medidata's recent win in the "Patient Engagement App Challenge" at the 23rd Annual Partnerships in Clinical Trials Conference. Medidata was granted the Large Organization Recognition Award for Engage, the company's app prototype, for its potential to positively transform the clinical trial experience for study participants.
Read

In the March 2014 issue of Journal for Clinical Studies, Medidata experts Stephen Young, Kyle Givens and Laurie Falkin evaluate whether or not risk-based monitoring is an appropriate methodology to use in emerging markets, analyzing several key risk indicators related to site quality and comparing them across global regions.
Read

Medidata's VP of product strategy Michelle Marlborough is featured in a March 2014 PharmaVOICE article on the future of connected health, in which she discusses the benefits of an mHealth strategy in the drug approval process.
Read

In a March 2014 PharmaVOICE article on how connected health tools improve patient outcomes, Medidata's VP of product strategy Michelle Marlborough shares how mHealth solutions and patient engagement technology can impact patient behavior.
Read

In a recent Journal for Clinical Studies article illustrating the impact of mobile technologies on the clinical research process, Medidata's solutions architect David Quarm describes how the mHealth landscape has changed over the past five years.
Read

Clinical Leader online reports on a recent Forbes' article, highlighting the growth of Medidata, the value the company's technology brings to its clients and its goal of digitizing the clinical trial process.
Read

Medidata President Glen de Vries is profiled by his alma mater Carnegie Mellon in the annual magazine of the Mellon College of Science, Science Connection. The article highlights how Glen's love for and knowledge of computers and biological sciences led him on the path to create Medidata Solutions, as well as how the company's cloud-based technology is transforming the clinical research landscape.
Read

Forbes' Matthew Herper profiles Medidata president Glen de Vries and CEO Tarek Sherif, telling of the company's history and success in the clinical trials technology space as well as its plan to continue enabling drug companies to save money in R&D.
Read

In a recent article published on Applied Clinical Trials online, Medidata expert Steve Young delves into the risk-based monitoring paradigm shift and how a "re-branding" of the term may lead to an increase in its adoption rate.
Read

In the January issue of PharmaVOICE, Medidata's Kyle Given is quoted in an article discussing the benefits of remote and risk-based monitoring, highlighting the mounting evidence that conducting 100 percent SDV minimally impacts data quality.
Read

2013

In a recent article in the November/December issue of Contract Pharma, Medidata's Rick Piazza explores the value of operational metrics in clinical development, highlighting how analytics can be leveraged to support important organizational goals, including efficiency, cost reduction and overall process improvement.
Read

In the November/December issue of PharmaVoice, Medidata president Glen de Vries provides insight into how mobile technologies will allow for news kinds of interaction between pharma companies, physicians and patients. Glen's sound bite appears in the "2014 Year in Preview" article, which features life science industry experts sharing predictions on the trends, challenges and opportunities in the coming year.
Read

Applied Clinical Trials online in October features a Medidata Insights™ benchmark blog showcasing eCRF data cleaning sources. Part of a series highlighting industry metrics, this edition focuses on the role auto queries play in acheiving optimal patient data quality.
Read

With the recent establishment of the Glen de Vries Permanent Fellowship Fund—which will provide tuition assistance to one student each year in the CDS master’s program at Courant Institute of Mathematical Sciences—NYU Center for Data Science tells Medidata president Glen de Vries' story on the start of Medidata, the key to its success (and Glen's role in it), and why he feels he has "the best job in the world."
Read 

Fierce Mobile Healthcare details the first Medidata-sponsored clinical trial, which will evaluate the impact of mobile and cloud-based technology on patient engagement for improved health outcomes in the diabetes community. In collaboration with Medidata Technology Partner Spaulding Clinical, the groundbreaking study will integrate Spaulding’s cloud-based webECG™ Management Solution, Withings’ mHealth devices—which monitor physical activity and weight—and the Medidata Clinical Cloud™ to engage patients in their own care.
Read

In a recent Applied Clinical Trials online article, Medidata client services principal Sean Neal offers background on common industry data standards, outlining the major upcoming changes to CDASH and describing how the CDISC organization aims to improve data standardization. 
Read

Fierce Biotech IT highlights Medidata's recent expanded partnership with Japanese-based pharma company Daiichi Sankyo. A long-time Medidata customer, Daiichi Sankyo has selected the Medidata Clinical Cloud™ to help streamline its clinical trials in China, utilizing the platform's applications for electronic data capture (EDC) and clinical data management (CDM), and randomization and trial supply management (RTSM).
Read

In a recent CIO.com article, Medidata’s global lead for patient cloud Anne Zielinski discusses the disruptive change that smartphones and “bring your own devices” will have on patient data collection in clinical trials.
Read

New York University announces that Medidata president and co-founder Glen de Vries has endowed the first student fellowship at New York University’s Center for Data Science. The Glen de Vries Permanent Fellowship Fund will support master’s students in the Center for Data Science program at NYU’s Courant Institute of Mathematical Sciences (CIMS).
Read

New York Governor Andrew M. Cuomo announces the expansion of Medidata's global headquarters in New York City and the expected growth of its roster of New York-based employees.
Read

The CNBC and Yahoo! Finance “Big Data Download” series features Medidata president Glen de Vries discussing how big data can help make the drug development process more efficient, cutting trial timelines and costs and ultimately creating better outcomes for patients.
Read

Medidata CEO Tarek Sherif is included in Chief Executive magazine's list of “Eight State Advocate CEOs,” part of its “2013 Best and Worst States for Business” series, and is highlighted for his role promoting other tech-entrepreneurship in NYC by mentoring CEOs of start-ups and supporting local university programs that foster business innovators.
Read

Speaking with TheStreet.com, Medidata CEO Tarek Sherif discusses how the Medidata Clinical Cloud is helping life science organizations bring better drugs to market, faster and with less cost and risk.
View

Applied Clinical Trials online features a recent Data Analysis blog showcasing two Medidata Insights™ benchmarks for data quality. Part of a series highlighting industry metrics, this edition focuses on the relationship between data quality and the cycle times for data cleaning and eCRF data entry.
Read

Medidata president Glen de Vries is named one of the “20 Innovators Changing the Face of the Clinical Trials Industry” in the April issue of The CenterWatch Monthly for pushing the envelope of cloud-based technologies in clinical development.
Read

The April issue of ACRP's The Monitor features Medidata senior product director Stephen Young as he discusses his career evolution from aerospace to the world of clinical development, and how his passion for analytics and data-driven development led him to this change.
Read

A recent FierceBiotechIT article highlights the roles of Medidata Solutions and Digital Infuzion in a groundbreaking observational study by Inova Translational Medicine Institute, which will examine the correlation between a child’s genetic profile, their development and their long-term health. Together, Medidata and Digital Infuzion will deliver a web-based portal and cloud technology that will act as a repository for patient data and will enable the review of study progress and access to surveys and study information.
Read

This FierceBiotechIT article offers insights from a recent webinar session, “Drugmakers go mobile,” moderated by executive editor Ryan McBride. Medidata Solutions president Glen de Vries presented—along with industry experts from Genentech, Dotmatics and Kony Solutions—on how pharma companies are embracing digital health and the use of mobile.
Read

Veeva Systems' blog Veeva Voice features a post by Medidata director of product marketing Jay Smith on the challenge and potential of cloud-based electronic trial master files (eTMF) and how they can revolutionize the management of clinical trials.
Read

In this eCliniqua article, Medidata product manager Igor Altman discusses the key issues for ensuring success when adopting new processes for study design optimization.
Read

In a recent Software Magazine article on the evolving healthcare industry and how it opens doors for new and improved IT solutions, Medidata president Glen de Vries discusses the meaningful use of electronic health record (EHR)/electronic medical record (EMR) systems and how Medidata’s cloud-based platform helps to reduce cost, reduce risk, and enhance efficiency in all stages of the clinical trial process.
Read

FierceBiotech highlights Purdue Pharma's recent multiyear deal with Medidata Solutions, broadening its already wide use of Medidata’s cloud-based solutions. The adoption will further enhance Purdue's clinical trials for pain medication.
Read

In a recent PharmaVOICE article on the future of the cloud in clinical research, Medidata president Glen de Vries shares his insight on how the cloud era will go beyond convenience and speed by bringing increased productivity across the trial team.
Read

In the January/February issue of Journal for Clinical Studies, Medidata’s vice president of trial planning solutions Frank Cattie discusses the three key variables of overall study cost—protocol complexity, geography and phase and indication—as well as ways for sponsors to control these variables, reduce study risk and increase performance predictability.
Read

Applied Clinical Trials online in January features a Medidata Insights benchmark for source document verification (SDV) coverage. Part of a monthly series highlighting industry metrics, this edition focuses on how FDA guidance on risk-based monitoring has impacted SDV coverage across the industry.
Read